These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8390340)
21. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746 [TBL] [Abstract][Full Text] [Related]
22. Endometrial morphology during a normophasic and a triphasic regimen: a comparison. Wynants P; Ide P Contraception; 1986 Feb; 33(2):149-57. PubMed ID: 2938885 [TBL] [Abstract][Full Text] [Related]
23. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives. Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683 [TBL] [Abstract][Full Text] [Related]
24. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA; Brenner PF; Kletzky OA; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817 [TBL] [Abstract][Full Text] [Related]
25. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration. Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955 [TBL] [Abstract][Full Text] [Related]
26. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics. Belsey EM; d'Arcangues C; Carlson N Contraception; 1988 Aug; 38(2):243-57. PubMed ID: 2971508 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate. Corson SL Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906 [TBL] [Abstract][Full Text] [Related]
28. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
29. GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer. Spicer DV; Shoupe D; Pike MC Contraception; 1991 Sep; 44(3):289-310. PubMed ID: 1662596 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Scott JZ; Kletzky OA; Brenner PF; Mishell DR Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356 [TBL] [Abstract][Full Text] [Related]
31. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach. Lemay A; Jean C; Faure N Fertil Steril; 1987 Nov; 48(5):775-82. PubMed ID: 2959569 [TBL] [Abstract][Full Text] [Related]
32. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059 [TBL] [Abstract][Full Text] [Related]
33. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
34. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study. Kamal I; Hefnawi F; Younis N Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506 [TBL] [Abstract][Full Text] [Related]
35. The effect of contraceptive steroids on hypothalamic-pituitary function. Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765 [TBL] [Abstract][Full Text] [Related]
36. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Belsey EM Contraception; 1988 Aug; 38(2):181-206. PubMed ID: 2971505 [TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation. Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739 [TBL] [Abstract][Full Text] [Related]
38. Effect of switching with oral contraceptives. Wassef SA; Sami G; Hamid EA Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511 [TBL] [Abstract][Full Text] [Related]
39. Carbohydrate metabolism of Indian women taking steroid contraceptives. Barsivala VM; Virkar K; Kulkarni RD Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247 [TBL] [Abstract][Full Text] [Related]
40. Contraception in older woman. Volpe A; Silferi M; Genazzani AD; Genazzani AR Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]